SlideShare a Scribd company logo
DR.AJIMSHA SHOUKATH
INTRODUCTION
 FEVER WITH RASH IS A COMMON VEXING PROBLEM.
 IT MAY SIGNIFY A SERIOUS DISORDER
(MENINGOCOCCEMIA OR DENGUE HAEMORRHAGIC
FEVER) OR MAY BE ASSOCIATED WITH MINOR DRUG
ALLERGY
 THERE ARE NON INFECTIOUS CAUSES ALSO
CAUSES
MACULAR OR MACULOPAPULAR RASH
VIRUS ADENOVIRUS, MEASLES
RUBELLA, ROSEOLA
ERYTHEMA INFECTIOSUM
EPSTEIN BARR VIRUS
ECHO VIRUS, HBV
HIV
BACTERIA ERYTHEMA MARGINATUM(RHEUMATIC
FEVER)
SCARLET FEVER ( GROUP A
STREPTOCOCCUS)
ERYSIPELAS
ARCANOBACTERIUM HAEMOLYTICUM
SECONDARY SYPHILIS
LEPTOSPIROSIS, PSEUDOMONAS
MENINGOCOCCAL INFECTION
SALMONELLA TYPHI, LYME DISEASE
MYCOPLASMA PNEUMONIAE
CONTD.
RICKETTTSIAE ROCKY MONTAIN SPOTTED FEVER
TYPHUS(SCRUB, ENDEMIC)
EHRLICHIOSIS
OTHER KAWASAKI DISEASE
RHEUMATOID ARTHRITIS
DRUG REACTION
DIFFUSE ERYTHRODERMA
BACTERIA SCARLET FEVER (GROUP A
STREPTOCOCCUS)
STAPHYLOCOCCAL SCALDED SYNDROME
TOXIC SHOCK SYNDROME (
STAPHYLOCOCCUS AUREUS)
FUNGI CAANDIDA ALBICANS
OTHER KAWASAKI SYNDROME
URTICARIAL RASH
VIRUSES EPSTEIN BARR VIRUS
HBV
HIV
BACTERIA M. PNEUMONIAE
GROUP A STREPTOCOCCUS
OTHER DRUG REACTION
VESICULAR, BULLOUS, PUSTULAR
VIRUSES HERPES SIMPLEX VIRUSES
VARIZELLA ZOSTER VIRUS
COXACKIEVIRUSES
BACTERIA STAPHYLOCOCCAL SCALDED SKIN
SYNDROME
STAPHYLOCOCCAL BULLOUS IMPETIGO
RICKETSSIAE RICKETSSIALPOX
OTHERS TOXIC EPIDERMAL NECROLYSIS
ERYTHEMA MULTIFORME(STEVENES-
JHONSON SYNDROME)
PETECHIAL PURPURIC
VIRUSES ADENOVIRUS
ATYPICAL MEASLES
CONGENITAL RUBELLA
CONGENITAL CMV,ENTERO VIRUS
PARVO VIRUS B 19
HIV, HAEMORRHAGIC FEVER VIRUS
BACTERIA SEPSIS(MENINGOCOCCAL, GONOCOCCAL,
PNEUMOCOCCAL, HAEMOPHILUS
INFLUENZAE TYPE B)
INFECTIVVE ENDOCARDITIS)
ECHTHYMA GANGRENOSUM(
RICKETSSIAE ROCKY MONTAIN SPOTTED FEVER
EPIDEMIC TYPHUS
EHRLICHIOSIS
FUNGI NECROTIC ESCHAR(ASPERGILLUS,
MUCOR)
OTHERS VASCULITIS, THROMBOCYTOPENIA
HENOCH-SCHONLEIN PURPURA
MALARIA
ERYHTMA NODOSUM
VIRUS EPSTEIN BARR VIRUS
HBV
BACTERIA GROUP A STREPTOCOCCUS
MYCOBACTERIUM TUBERCULOSIS
YERSINIA
CAT SCRATCH DISEASE
FUNGI COCCIDIOMYCOSIS
HISTOPLASMOSIS
OTHERS SARCOIDOSIS
INFLAMMATORY BOWEL DISEASE
ESTROGEN CONTAINING OCP
SLE
BEHCETS DISEASE
Uncommon disease- scarlet fever,
Kawasaki disease
HISTORY
 AGE
 DURATION DISTRIBUTION AND PROGRESSION OF THE RASH
 TRAVEL/ LOCATION
 SICK CONTACTS
 HISTORY OF DRUG INTAKE
 VACCINATIONS
 PREVIOUS EXANTHEMS
 SEASON
 INVOLVEMENT OF MUCOUS MEMBRANE
 ASSOCIATED SYMPTOMS- ITCHING( CHICKEN POX)-
FEVER(INFECTIOUS CAUSES)-PAIN
DETAILS OF RASHES
 SITE OF ONSET
 DIRECTION OF SPREAD
 PRESENCE OR ABSENT OF PRURITIS
 RELATIONSHIP WITH FEVER AND RASH
 IMPORTANT TO KNOW ANY TOPICAL OR ORAL
MEDICATION APPLIED OR NOT.
EXAMINATION
 PATIENT’S VITAL SIGN AND GENERAL APPEARANCE
 SIGN OF TOXICITY
 LYMPHADENOPATHY
 ORAL, GENITAL OR CONJUNCTIVA LESION
 HEPATO-SPLENOMEGALY
 EVIDENCES OF EXCORIATION AND TENDERNESS
 SIGN OF NECK RIGIDITY OR NEUROLOGICAL
DYSFUNCTION.
INVESTIGATIONS
 ROUTINE INVESTIGATIONS
o TOTAL COUNT , DIFFERENTIAL LEUCOCYTE COUNT
o ESR
MEASLES
 ETIOLOGY- SINGLE STRANDED PARAMYXO VIRUS
 MODE OF TRANSMISSION:
CONTACT WITH SECRETIONS OR DROPLETS OF AN INFECTED CHILD.
 PERIOD OF INFECTIVITY:
4 DAYS PRIOR TO AND 5 DAYS AFTER APPEARANCE OF THE RASH.
 CLINICAL MANIFESTATIONS:
o AN INCUBATION STAGE 10-12 DAYS
o PRODROMAL STAGE WITH AN ENANTHEM (KOPLIK SPOTS), USUALLY LASTS
3-5 DAYS. KOPLIK SPOTS ARE GRAYISH WHITE DOTS ON AN
ERYTHEMATOUS BASE ON THE ANTERIOR PORTION OF THE BUCCAL
MUCOSA. WITH APPEARANCE OF RASH, KOPLIK SPOTS START TO
DISAPPEAR.
 FINAL STAGE STARTS WITH A
MACULOPAPULAR RASH ACCOMPANIED BY
HIGH FEVER. THE RASH STARTS BEHIND
THE EARS, AND ALONG THE HAIRLINE.
THEN THE RASH SPREADS ON THE FACE,
NECK, UPPER ARMS, AND UPPER PART OF
THE CHEST WITHIN THE FIRST 24 HOURS.
 ON 2ND DAY. THE RASH APPEARS ON THE
BACK, ABDOMEN, ARMS AND THIGHS.
 ON 3RD DAY. IT REACHES THE FEET AND
BEGINS TO FADE ON THE FACE.
 AN ABRUPT DROP IN TEMPERATURE TO
NORMAL. THE RASH FADES DOWNWARD
IN THE SAME SEQUENCE IN WHICH IT
APPEARED
 DIAGNOSIS: CLINICAL FEATURES BUT LABORATORY TESTS IS RARELY
NEEDED.
 LEUKOCYTIC COUNT TENDS TO BE LOW WITH A RELATIVE LYMPHOCYTOSIS.
LEUCOCYTOSIS IS INDICATIVE OF SECONDARY BACTERIAL INFECTION.
 COMPLICATIONS: THE MAIN COMPLICATIONS OF MEASLES ARE
 OTITIS MEDIA AND PNEUMONIA.
 ENCEPHALITIS;
 DIARRHEA AND DYSENTERY.
 ACTIVATION OF A TUBERCULOUS FOCUS.
TREATMENT
SUPPORTIVE THERAPY:
 ANTIPYRETICS (PARACETAMOL)
 BED REST AND AN ADEQUATE FLUID INTAKE ARE INDICATED.
 A NOURISHING EASILY DIGESTED DIET AND PROPER CLEANLINESS.
 VITAMIN A: A SINGLE DOSE OF 50,000 TO 200,000 IU.
 A BROAD SPECTRUM ANTIBIOTIC IN PRESENCE OF INFECTIONS.
 PREVENTION:
 ISOLATION SHOULD BE MAINTAINED FROM THE 7TH DAY AFTER EXPOSURE
UNTIL 5 DAYS AFTER THE RASH HAS APPEARED.
 MEASLES VACCINE.
 POST-EXPOSURE PROPHYLAXIS.
RUBELLA
 ETIOLOGY: RUBELLA VIRUS (AN RNA VIRUS).
 INCUBATION PERIOD: 2-3 WEEKS.
 MODE OF TRANSMISSION:
DROPLET INFECTION OR DIRECT CONTACT WITH A CASE
 PRODROMAL STAGE: VERY SHORT AND MILD THAT IT GOES
UNNOTICED.
 INFECTIVITY : NOT AS CONTAGIOUS AS MEASLES.
 VIRUS IS PRESENT IN NASOPHARYNGEAL
SECRETIONS, BLOOD, FAECES AND URINE.
 VIRUS HAS BEEN RECOVERED FROM THE NASOPHARYNX 7 DAYS
BEFORE EXANTHEMA AND 7-8 DAYS AFTER ITS DISAPPEARANCE.
 INFANTS WITH CONGENITAL RUBELLA ARE CONTAGIOUS FOR
ATLEAST 10-12 MONTHS.
CLINICAL MANIFESTATIONS
 AGE: ANY AGE, PEAK INCIDENCE 5-14 YEARS
 LYMPHADENOPATHY IS EVIDENT AT LEAST 24HR BEFORE THE RASH
APPEARS.
 THE EXANTHEM BEGINS ON THE FACE AND SPREADS QUICKLY ON THE
FIRST DAY.
 2ND DAY. THE RASH IS CONFLUENT AND PINPOINT LIKE THAT OF SCARLET
FEVER WITH MILD ITCHING.
 3RD DAY. THE RASH GENERALLY DISAPPEARS WITH MINIMAL
DESQUAMATION AND NO SCARING.
 RUBELLA WITHOUT RASH MAY OCCUR AS FEVER WITH ENLARGED TENDER
LYMPHADENOPATHY WHICH MAY PERSIST FOR A WEEK OR MORE.
COMPLICATIONS:
COMPLICATIONS ARE RELATIVELY UNCOMMON IN CHILDHOOD.
 ENCEPHALITIS SIMILAR TO THAT SEEN WITH MEASLES
 POLYARTHRITIS
PROPHYLAXIS:
 ACTIVE IMMUNIZATION (MMR VACCINE)
-MMR VACCINE SHOULD NOT BE GIVEN TO PREGNANT WOMEN;
VACCINATED WOMEN SHOULD AVOID PREGNANCY FOR 3 MONTHS
AFTER VACCINATION. NATURAL INFECTION GIVES LIFE- LONG
IMMUNITY.
 PASSIVE IMMUNIZATION. IT IS NOT INDICATED EXCEPT IN NON-
IMMUNE PREGNANT WOMEN. IMMUNE SERUM GLOBULIN (ISG) IN
BIG DOSES IS GIVEN I.M WITHIN ONE WEEK OF EXPOSURE.
TREATMENT:
1- ANTIPYRETICS FOR FEVER. 2- TREATMENT OF COMPLICATIONS
CONGENITAL RUBELLA
 IF RUBELLA DEVELOPS DURING THE FIRST TRIMESTER OF PREGNANCY, (WHICH IS
THE PERIOD OF ORGANOGENESIS).
 TRANSPLACENTAL CONGENITAL INFECTION FROM INFECTED MOTHER.
 FEATURES OF CONGENITAL RUBELLA SYNDROME:
1-INTRAUTERINE GROWTH RETARDATION, SMALL FOR GESTATIONAL AGE AND FAILURE
TO THRIVE
2-NERVE DEAFNESS
3- MICROCEPHALY AND MENTAL RETARDATION
4- CONGENITAL HEART DISEASE (PDA, VSD)
5- CATARACT, GLAUCOMA, AND CLOUDY CORNEA
6- THROMBOCYTOPENIC PURPURA, HEPATOSPLENOMEGALY, AND OSTEOPATHY
CHICKEN POX (VARICELLA)
 THIS IS A HIGHLY CONTAGIOUS INFECTION CHARACTERIZED BY
A PLEOMORPHIC RASH.
 ETIOLOGY: VARICELLA-ZOSTER VIRUS WHICH CAUSE CHICKEN
POX IN A NON IMMUNE AND HERPES ZOSTER IN A PARTIALLY
IMMUNE INDIVIDUAL.
 MODE OF INFECTION:
1. DIRECT CONTACT.
2. DROPLET INFECTION.
3. AIR BORNE.
 PERIOD OF INFECTIVITY: EXTENDS FROM ONE DAY BEFORE
THE ONSET OF RASH TILL CRUSTED.
 INCUBATION PERIOD: 2-3 WEEKS.
CLINICAL MANIFESTATIONS:
 AGE: ANY AGE , THE MOST COMMON FROM 5-10 YEARS.
 PRODROMAL STAGE: VERY MILD AND SHORT.
 ERUPTION STAGE: (PLEOMORPHIC RASHES), ALL FORMS OF
LESIONS BEING PRESENT.
 THE RASH APPEARS AS CROPS OF MACULES WHICH WITHIN
HOURS PASS THROUGH A PAPULAR STAGE, THEN PROGRESS
TO DEVELOP VESICLES AND PUSTULES.
 PRURITUS MAY BE INTENSE. -THE RASH MAY APPEAR ON
MUCOUS MEMBRANES WITH ULCERATION IN THE MOUTH.
COMPLICATIONS:
 SECONDARY BACTERIAL INFECTION OF SKIN LESIONS.
 HEMORRHAGIC COMPLICATIONS: THROMBOCYTOPENIA,
PURPURA, HEMATURIA, AND GASTROINTESTINAL
HEMORRHAGE.
 ENCEPHALITIS AND CEREBELLAR ATAXIA.
 REYE SYNDROME: ENCEPHALOPATHY AND HEPATIC
DYSFUNCTION.
TREATMENT:
 LOCAL AND SYSTEMIC ANTIHISTAMINIC TO ALLEVIATE
ITCHING.
 NON- ASPIRIN ANTIPYRETICS (E.G. PARACETAMOL).
 LOCAL APPLICATION OF CALAMINE LOTION.
 PATIENTS AT RISK OF SEVERE CHICKENPOX SHOULD
RECEIVE ACYCLOVIR (ANTIVIRAL AGENT).
 TREATMENT OF COMPLICATIONS.

More Related Content

PPTX
approach to child with fever and Rash
PPTX
2. fever with rash
PDF
Fever with Rash
PPTX
Pediatrics Review Booklet by Dr. Aryan (Medical Booklet Series by Dr. Aryan P...
PPTX
Fever with rash in dermatology.
PPTX
Hypovolemia
PPTX
Approach to Skin rash
PPTX
Fever and Rash
approach to child with fever and Rash
2. fever with rash
Fever with Rash
Pediatrics Review Booklet by Dr. Aryan (Medical Booklet Series by Dr. Aryan P...
Fever with rash in dermatology.
Hypovolemia
Approach to Skin rash
Fever and Rash

What's hot (20)

PPTX
Paediatric rashes
PDF
Approach to child – fever with rash
PDF
Fever with a maculopapular skin rash in children 2021
PPTX
Enteric fever in pediatrics
PPTX
Fever & Rash
PPTX
Scarlet fever ( infectious diseases )
PPTX
pediatric Systemic lupus erythematosus
PPTX
Approach to a child with fever and rash
PPTX
Enteric Fever in Pediatrics ( Typhoid ) Dr Padmesh
PPTX
Post streptococcal glomerulonephritis
PPT
Viral exanthems
PPTX
Common pediatric skin rash
DOC
External markers of tuberculosis
PPTX
Cerebral Malaria
PPTX
Genital ulcer
PPTX
scrub typhus
PPT
Dengue Hemorrhagic fever
PPT
Congenitalsyphilis
Paediatric rashes
Approach to child – fever with rash
Fever with a maculopapular skin rash in children 2021
Enteric fever in pediatrics
Fever & Rash
Scarlet fever ( infectious diseases )
pediatric Systemic lupus erythematosus
Approach to a child with fever and rash
Enteric Fever in Pediatrics ( Typhoid ) Dr Padmesh
Post streptococcal glomerulonephritis
Viral exanthems
Common pediatric skin rash
External markers of tuberculosis
Cerebral Malaria
Genital ulcer
scrub typhus
Dengue Hemorrhagic fever
Congenitalsyphilis
Ad

Viewers also liked (11)

PPT
National Dengue Management Guideline for Bangladesh
PPTX
PPT
dengue
PPT
Dengue Hemorrhagic Fever Management
PPTX
Management of Dengue Fever/ Dengue Hemorrhagic Fever
PDF
Nelson pediatrics review (mcqs) 19ed
PDF
Core clinical cases in pediatrics
PPTX
Paediatrics - Case presentation: fever+rash
PPTX
Dengue fever slide
PPT
National Dengue Management Guideline for Bangladesh
dengue
Dengue Hemorrhagic Fever Management
Management of Dengue Fever/ Dengue Hemorrhagic Fever
Nelson pediatrics review (mcqs) 19ed
Core clinical cases in pediatrics
Paediatrics - Case presentation: fever+rash
Dengue fever slide
Ad

Similar to Approach to fever with rashes (20)

PPTX
chickenpox
PPTX
diseases chicken box suraj-170224155357.pptx
PPTX
chicken box symptoms ,and zoster virus.pptx
PPTX
CHICKENPOX ppt
PPTX
PPTX
chickenpox
PPTX
Chickenpox,measles,small pox,rubella
PPTX
Meningitis in Children.
PPTX
CHICKEN POX DISESES
PPTX
Viral infections / 4th stage students / Dr. Alaa Awn
PDF
RNA VIRUSES NEGATIVE SENSE - MS SABADO AND MANUEL_20240524_085956_0000.pdf
PPTX
Ocular virology
PPT
Detailed notes PARAMYXOVIRIDAE FAMILY.ppt
PPTX
Dna viruses
PDF
03- Viral Skin Infections - Dr Ayman Al-Wadei.pdf
PPTX
‫viral rrrrrrrrrrrrrrrrrrrrrrrrrrrrr.pptx
PDF
A quick walk through the world of microbiology-Patrick Nkemba
PPTX
HERPES ZOSTER (shingles)
PPTX
Prevention and control of Chickenpox.pptx
PPTX
Fever and rash by Dr.Uma
chickenpox
diseases chicken box suraj-170224155357.pptx
chicken box symptoms ,and zoster virus.pptx
CHICKENPOX ppt
chickenpox
Chickenpox,measles,small pox,rubella
Meningitis in Children.
CHICKEN POX DISESES
Viral infections / 4th stage students / Dr. Alaa Awn
RNA VIRUSES NEGATIVE SENSE - MS SABADO AND MANUEL_20240524_085956_0000.pdf
Ocular virology
Detailed notes PARAMYXOVIRIDAE FAMILY.ppt
Dna viruses
03- Viral Skin Infections - Dr Ayman Al-Wadei.pdf
‫viral rrrrrrrrrrrrrrrrrrrrrrrrrrrrr.pptx
A quick walk through the world of microbiology-Patrick Nkemba
HERPES ZOSTER (shingles)
Prevention and control of Chickenpox.pptx
Fever and rash by Dr.Uma

Approach to fever with rashes

  • 2. INTRODUCTION  FEVER WITH RASH IS A COMMON VEXING PROBLEM.  IT MAY SIGNIFY A SERIOUS DISORDER (MENINGOCOCCEMIA OR DENGUE HAEMORRHAGIC FEVER) OR MAY BE ASSOCIATED WITH MINOR DRUG ALLERGY  THERE ARE NON INFECTIOUS CAUSES ALSO
  • 3. CAUSES MACULAR OR MACULOPAPULAR RASH VIRUS ADENOVIRUS, MEASLES RUBELLA, ROSEOLA ERYTHEMA INFECTIOSUM EPSTEIN BARR VIRUS ECHO VIRUS, HBV HIV BACTERIA ERYTHEMA MARGINATUM(RHEUMATIC FEVER) SCARLET FEVER ( GROUP A STREPTOCOCCUS) ERYSIPELAS ARCANOBACTERIUM HAEMOLYTICUM SECONDARY SYPHILIS LEPTOSPIROSIS, PSEUDOMONAS MENINGOCOCCAL INFECTION SALMONELLA TYPHI, LYME DISEASE MYCOPLASMA PNEUMONIAE
  • 4. CONTD. RICKETTTSIAE ROCKY MONTAIN SPOTTED FEVER TYPHUS(SCRUB, ENDEMIC) EHRLICHIOSIS OTHER KAWASAKI DISEASE RHEUMATOID ARTHRITIS DRUG REACTION
  • 5. DIFFUSE ERYTHRODERMA BACTERIA SCARLET FEVER (GROUP A STREPTOCOCCUS) STAPHYLOCOCCAL SCALDED SYNDROME TOXIC SHOCK SYNDROME ( STAPHYLOCOCCUS AUREUS) FUNGI CAANDIDA ALBICANS OTHER KAWASAKI SYNDROME URTICARIAL RASH VIRUSES EPSTEIN BARR VIRUS HBV HIV BACTERIA M. PNEUMONIAE GROUP A STREPTOCOCCUS OTHER DRUG REACTION
  • 6. VESICULAR, BULLOUS, PUSTULAR VIRUSES HERPES SIMPLEX VIRUSES VARIZELLA ZOSTER VIRUS COXACKIEVIRUSES BACTERIA STAPHYLOCOCCAL SCALDED SKIN SYNDROME STAPHYLOCOCCAL BULLOUS IMPETIGO RICKETSSIAE RICKETSSIALPOX OTHERS TOXIC EPIDERMAL NECROLYSIS ERYTHEMA MULTIFORME(STEVENES- JHONSON SYNDROME)
  • 7. PETECHIAL PURPURIC VIRUSES ADENOVIRUS ATYPICAL MEASLES CONGENITAL RUBELLA CONGENITAL CMV,ENTERO VIRUS PARVO VIRUS B 19 HIV, HAEMORRHAGIC FEVER VIRUS BACTERIA SEPSIS(MENINGOCOCCAL, GONOCOCCAL, PNEUMOCOCCAL, HAEMOPHILUS INFLUENZAE TYPE B) INFECTIVVE ENDOCARDITIS) ECHTHYMA GANGRENOSUM( RICKETSSIAE ROCKY MONTAIN SPOTTED FEVER EPIDEMIC TYPHUS EHRLICHIOSIS FUNGI NECROTIC ESCHAR(ASPERGILLUS, MUCOR) OTHERS VASCULITIS, THROMBOCYTOPENIA HENOCH-SCHONLEIN PURPURA MALARIA
  • 8. ERYHTMA NODOSUM VIRUS EPSTEIN BARR VIRUS HBV BACTERIA GROUP A STREPTOCOCCUS MYCOBACTERIUM TUBERCULOSIS YERSINIA CAT SCRATCH DISEASE FUNGI COCCIDIOMYCOSIS HISTOPLASMOSIS OTHERS SARCOIDOSIS INFLAMMATORY BOWEL DISEASE ESTROGEN CONTAINING OCP SLE BEHCETS DISEASE
  • 9. Uncommon disease- scarlet fever, Kawasaki disease
  • 10. HISTORY  AGE  DURATION DISTRIBUTION AND PROGRESSION OF THE RASH  TRAVEL/ LOCATION  SICK CONTACTS  HISTORY OF DRUG INTAKE  VACCINATIONS  PREVIOUS EXANTHEMS  SEASON  INVOLVEMENT OF MUCOUS MEMBRANE  ASSOCIATED SYMPTOMS- ITCHING( CHICKEN POX)- FEVER(INFECTIOUS CAUSES)-PAIN
  • 11. DETAILS OF RASHES  SITE OF ONSET  DIRECTION OF SPREAD  PRESENCE OR ABSENT OF PRURITIS  RELATIONSHIP WITH FEVER AND RASH  IMPORTANT TO KNOW ANY TOPICAL OR ORAL MEDICATION APPLIED OR NOT.
  • 12. EXAMINATION  PATIENT’S VITAL SIGN AND GENERAL APPEARANCE  SIGN OF TOXICITY  LYMPHADENOPATHY  ORAL, GENITAL OR CONJUNCTIVA LESION  HEPATO-SPLENOMEGALY  EVIDENCES OF EXCORIATION AND TENDERNESS  SIGN OF NECK RIGIDITY OR NEUROLOGICAL DYSFUNCTION.
  • 13. INVESTIGATIONS  ROUTINE INVESTIGATIONS o TOTAL COUNT , DIFFERENTIAL LEUCOCYTE COUNT o ESR
  • 14. MEASLES  ETIOLOGY- SINGLE STRANDED PARAMYXO VIRUS  MODE OF TRANSMISSION: CONTACT WITH SECRETIONS OR DROPLETS OF AN INFECTED CHILD.  PERIOD OF INFECTIVITY: 4 DAYS PRIOR TO AND 5 DAYS AFTER APPEARANCE OF THE RASH.  CLINICAL MANIFESTATIONS: o AN INCUBATION STAGE 10-12 DAYS o PRODROMAL STAGE WITH AN ENANTHEM (KOPLIK SPOTS), USUALLY LASTS 3-5 DAYS. KOPLIK SPOTS ARE GRAYISH WHITE DOTS ON AN ERYTHEMATOUS BASE ON THE ANTERIOR PORTION OF THE BUCCAL MUCOSA. WITH APPEARANCE OF RASH, KOPLIK SPOTS START TO DISAPPEAR.
  • 15.  FINAL STAGE STARTS WITH A MACULOPAPULAR RASH ACCOMPANIED BY HIGH FEVER. THE RASH STARTS BEHIND THE EARS, AND ALONG THE HAIRLINE. THEN THE RASH SPREADS ON THE FACE, NECK, UPPER ARMS, AND UPPER PART OF THE CHEST WITHIN THE FIRST 24 HOURS.  ON 2ND DAY. THE RASH APPEARS ON THE BACK, ABDOMEN, ARMS AND THIGHS.  ON 3RD DAY. IT REACHES THE FEET AND BEGINS TO FADE ON THE FACE.  AN ABRUPT DROP IN TEMPERATURE TO NORMAL. THE RASH FADES DOWNWARD IN THE SAME SEQUENCE IN WHICH IT APPEARED
  • 16.  DIAGNOSIS: CLINICAL FEATURES BUT LABORATORY TESTS IS RARELY NEEDED.  LEUKOCYTIC COUNT TENDS TO BE LOW WITH A RELATIVE LYMPHOCYTOSIS. LEUCOCYTOSIS IS INDICATIVE OF SECONDARY BACTERIAL INFECTION.  COMPLICATIONS: THE MAIN COMPLICATIONS OF MEASLES ARE  OTITIS MEDIA AND PNEUMONIA.  ENCEPHALITIS;  DIARRHEA AND DYSENTERY.  ACTIVATION OF A TUBERCULOUS FOCUS.
  • 17. TREATMENT SUPPORTIVE THERAPY:  ANTIPYRETICS (PARACETAMOL)  BED REST AND AN ADEQUATE FLUID INTAKE ARE INDICATED.  A NOURISHING EASILY DIGESTED DIET AND PROPER CLEANLINESS.  VITAMIN A: A SINGLE DOSE OF 50,000 TO 200,000 IU.  A BROAD SPECTRUM ANTIBIOTIC IN PRESENCE OF INFECTIONS.  PREVENTION:  ISOLATION SHOULD BE MAINTAINED FROM THE 7TH DAY AFTER EXPOSURE UNTIL 5 DAYS AFTER THE RASH HAS APPEARED.  MEASLES VACCINE.  POST-EXPOSURE PROPHYLAXIS.
  • 18. RUBELLA  ETIOLOGY: RUBELLA VIRUS (AN RNA VIRUS).  INCUBATION PERIOD: 2-3 WEEKS.  MODE OF TRANSMISSION: DROPLET INFECTION OR DIRECT CONTACT WITH A CASE  PRODROMAL STAGE: VERY SHORT AND MILD THAT IT GOES UNNOTICED.  INFECTIVITY : NOT AS CONTAGIOUS AS MEASLES.  VIRUS IS PRESENT IN NASOPHARYNGEAL SECRETIONS, BLOOD, FAECES AND URINE.  VIRUS HAS BEEN RECOVERED FROM THE NASOPHARYNX 7 DAYS BEFORE EXANTHEMA AND 7-8 DAYS AFTER ITS DISAPPEARANCE.  INFANTS WITH CONGENITAL RUBELLA ARE CONTAGIOUS FOR ATLEAST 10-12 MONTHS.
  • 19. CLINICAL MANIFESTATIONS  AGE: ANY AGE, PEAK INCIDENCE 5-14 YEARS  LYMPHADENOPATHY IS EVIDENT AT LEAST 24HR BEFORE THE RASH APPEARS.  THE EXANTHEM BEGINS ON THE FACE AND SPREADS QUICKLY ON THE FIRST DAY.  2ND DAY. THE RASH IS CONFLUENT AND PINPOINT LIKE THAT OF SCARLET FEVER WITH MILD ITCHING.  3RD DAY. THE RASH GENERALLY DISAPPEARS WITH MINIMAL DESQUAMATION AND NO SCARING.  RUBELLA WITHOUT RASH MAY OCCUR AS FEVER WITH ENLARGED TENDER LYMPHADENOPATHY WHICH MAY PERSIST FOR A WEEK OR MORE.
  • 20. COMPLICATIONS: COMPLICATIONS ARE RELATIVELY UNCOMMON IN CHILDHOOD.  ENCEPHALITIS SIMILAR TO THAT SEEN WITH MEASLES  POLYARTHRITIS PROPHYLAXIS:  ACTIVE IMMUNIZATION (MMR VACCINE) -MMR VACCINE SHOULD NOT BE GIVEN TO PREGNANT WOMEN; VACCINATED WOMEN SHOULD AVOID PREGNANCY FOR 3 MONTHS AFTER VACCINATION. NATURAL INFECTION GIVES LIFE- LONG IMMUNITY.  PASSIVE IMMUNIZATION. IT IS NOT INDICATED EXCEPT IN NON- IMMUNE PREGNANT WOMEN. IMMUNE SERUM GLOBULIN (ISG) IN BIG DOSES IS GIVEN I.M WITHIN ONE WEEK OF EXPOSURE. TREATMENT: 1- ANTIPYRETICS FOR FEVER. 2- TREATMENT OF COMPLICATIONS
  • 21. CONGENITAL RUBELLA  IF RUBELLA DEVELOPS DURING THE FIRST TRIMESTER OF PREGNANCY, (WHICH IS THE PERIOD OF ORGANOGENESIS).  TRANSPLACENTAL CONGENITAL INFECTION FROM INFECTED MOTHER.  FEATURES OF CONGENITAL RUBELLA SYNDROME: 1-INTRAUTERINE GROWTH RETARDATION, SMALL FOR GESTATIONAL AGE AND FAILURE TO THRIVE 2-NERVE DEAFNESS 3- MICROCEPHALY AND MENTAL RETARDATION 4- CONGENITAL HEART DISEASE (PDA, VSD) 5- CATARACT, GLAUCOMA, AND CLOUDY CORNEA 6- THROMBOCYTOPENIC PURPURA, HEPATOSPLENOMEGALY, AND OSTEOPATHY
  • 22. CHICKEN POX (VARICELLA)  THIS IS A HIGHLY CONTAGIOUS INFECTION CHARACTERIZED BY A PLEOMORPHIC RASH.  ETIOLOGY: VARICELLA-ZOSTER VIRUS WHICH CAUSE CHICKEN POX IN A NON IMMUNE AND HERPES ZOSTER IN A PARTIALLY IMMUNE INDIVIDUAL.  MODE OF INFECTION: 1. DIRECT CONTACT. 2. DROPLET INFECTION. 3. AIR BORNE.  PERIOD OF INFECTIVITY: EXTENDS FROM ONE DAY BEFORE THE ONSET OF RASH TILL CRUSTED.  INCUBATION PERIOD: 2-3 WEEKS.
  • 23. CLINICAL MANIFESTATIONS:  AGE: ANY AGE , THE MOST COMMON FROM 5-10 YEARS.  PRODROMAL STAGE: VERY MILD AND SHORT.  ERUPTION STAGE: (PLEOMORPHIC RASHES), ALL FORMS OF LESIONS BEING PRESENT.  THE RASH APPEARS AS CROPS OF MACULES WHICH WITHIN HOURS PASS THROUGH A PAPULAR STAGE, THEN PROGRESS TO DEVELOP VESICLES AND PUSTULES.  PRURITUS MAY BE INTENSE. -THE RASH MAY APPEAR ON MUCOUS MEMBRANES WITH ULCERATION IN THE MOUTH.
  • 24. COMPLICATIONS:  SECONDARY BACTERIAL INFECTION OF SKIN LESIONS.  HEMORRHAGIC COMPLICATIONS: THROMBOCYTOPENIA, PURPURA, HEMATURIA, AND GASTROINTESTINAL HEMORRHAGE.  ENCEPHALITIS AND CEREBELLAR ATAXIA.  REYE SYNDROME: ENCEPHALOPATHY AND HEPATIC DYSFUNCTION.
  • 25. TREATMENT:  LOCAL AND SYSTEMIC ANTIHISTAMINIC TO ALLEVIATE ITCHING.  NON- ASPIRIN ANTIPYRETICS (E.G. PARACETAMOL).  LOCAL APPLICATION OF CALAMINE LOTION.  PATIENTS AT RISK OF SEVERE CHICKENPOX SHOULD RECEIVE ACYCLOVIR (ANTIVIRAL AGENT).  TREATMENT OF COMPLICATIONS.